Author Archives: admin


Tvardi Therapeutics to Participate in the TD Cowen 45th Annual Health Care Conference

HOUSTON, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Tvardi Therapeutics, Inc. (“Tvardi”), a clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule therapies targeting STAT3 to treat fibrosis-driven diseases, today announced that it will participate in the TD Cowen 45th Annual Health Care Conference. Tvardi management will host investor one-on-one investor meetings on March 3 – 5, 2025.

More:
Tvardi Therapeutics to Participate in the TD Cowen 45th Annual Health Care Conference

Annovis to Host Patients’ Live Forum on February 27, 2025

MALVERN, Pa., Feb. 19, 2025 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio, Inc. (NYSE: ANVS)  ("Annovis" or the "Company"), a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s disease (PD), will host a live webcast where CEO Maria Maccecchini, Ph.D., will answer questions from patients, caregivers, and families about the Company’s clinical trials and future plans.

Original post:
Annovis to Host Patients’ Live Forum on February 27, 2025